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Abstract By using our recently developed gene discovery sys-
tem, we have identi¢ed Bak, a member of the Bcl-2 family, as a
pro-apoptotic factor in the tumor necrosis factor (TNF)-K-in-
duced apoptotic pathway in caspase 3-de¢cient cells. Unlike
Bcl-2, Bak stimulates several apoptotic pathways, however the
molecular mechanism(s) of its action remains unclear. For ex-
ample, it is unclear whether Bak induces apoptosis in caspase
3-de¢cient cells. In this study, we examined the e¡ects of over-
expression of Bak in MCF-7 cells that lack caspase 3. We
found that despite the absence of caspase 3 in MCF-7 cells,
they were more sensitive to the cell death e¡ects of Bak as
compared to caspase 3-expressing HeLa S3 cells. The targeting
of Bak function by ribozymes suggests that Bak is required for
the TNF-K-induced apoptotic pathway in caspase 3-de¢cient
cells. This study demonstrates the caspase 3-independent func-
tion of Bak in the TNF-K-induced apoptotic pathway. 1 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
To improve the e⁄ciency of ribozymes for cleaving their
target RNAs in vivo, we initially constructed ribozymes with
better accessibility and speci¢city to the target sites [1^8]. This
was obtained by combining the cleavage activity of a hammer-
head ribozyme with the unwinding activity of an endogenous
RNA helicase(s) that was recruited by a poly(A) motif linked
to the ribozyme (tRNAVal-Rz-A60) [9^11]. We demonstrated
that such a novel poly(A)-connected hybrid ribozyme has sub-
strate-unwinding activity and stronger cleavage activity. We
then constructed a randomized ribozyme library and demon-
strated its use for the identi¢cation of genes by a loss of
phenotype approach [9^12]. Sequencing of transfected ribo-
zyme from cells that lose a selected phenotype led to the rapid
identi¢cation of genes involved in that phenotype. We em-
ployed this rapid gene discovery protocol to identify genes
involved in tumor necrosis factor (TNF)-K-induced apoptosis
in caspase 3-de¢cient MCF-7 cells and identi¢ed Bak as one
of the genes [11]. The Bcl-2 family of proteins plays a central
role in the regulation of programmed cell death (apoptosis),
which is induced by a wide variety of stimuli such as serum
deprivation, the FAS antigen and TNF-K [14^18]. The pro-
apoptotic protein Bak, an antagonist of Bcl-2 and its homo-
logs, has been cloned and identi¢ed as an E1B19K-binding
protein. Since E1B19K is known to inhibit apoptosis, it has
been suggested that the E1B19K protein functions, at least in
part, by binding to the pro-apoptotic Bak protein and inhib-
iting its pro-apoptotic function. Recent studies have revealed
that overexpression of Bak causes apoptosis of cancer cells
[19^21]. However, the molecular basis of the actions of Bak
remains unclear. It has been proposed that Bak functions in a
caspase 3-dependent manner [13], however we have identi¢ed
Bak as a mediator of the TNF-K-induced apoptosis pathway
in MCF-7 cells which lack caspase 3 [11]. We have now char-
acterized the role of Bak in caspase 3-de¢cient (MCF-7) and
expressing (HeLa S3) cells by its exogenous expression and
targeting by hammerhead ribozymes. Our study demonstrates
that in addition to its previously described caspase 3-depen-
dent function [13], Bak has a caspase 3-independent role in
TNF-K-induced apoptosis.
2. Materials and methods
2.1. Construction of Bak-expressing and -targeting vectors
Human Bak cDNA was cloned from a cDNA library derived from
human heart (TaKaRa, Tokyo, Japan) by PCR ampli¢cation. Primers
were based on the published DNA sequence [19] as follows: Bak sense
5P-GAA TTC ATG GCT TCG GGG CAA GGC CCA-3P and anti-
sense 5P-GGA TCC TCA TGA TTT GAA GAA TCT TCG T-3P.
Sequences of the PCR-ampli¢ed Bak fragment were con¢rmed by
direct sequencing. The desired cDNA fragment was cloned into the
NotI and BamHI sites of pEGFP-c2 and the EcoRI and BamHI sites
of pIRESpuro (Clontech, CA, USA) respectively. The Bak-targeting
hammerhead ribozyme plasmid was constructed as described previ-
ously [5,8]. All plasmids were con¢rmed for their sequence integrity
by direct sequencing.
2.2. Cell culture, transfection and microscopy
MCF-7 human breast carcinoma cells were a gift from Dr. Wang
(University of South Florida College of Medicine, USA). Cells were
maintained routinely in minimal essential medium (MEM) supple-
mented with 10% fetal bovine serum, 100 WM non-essential amino
acids and 1 mM sodium pyruvate (Gibco BRL, MD, USA) in an
atmosphere of 5% CO2 in air at 37‡C. HeLa S3 cells (RIKEN gene
bank, Wako, Japan: no. RCB0191) were also maintained in MEM
plus 10% fetal bovine serum. Cells were transfected with the cationic
transfection reagent Trans-IT LT1 (Mirus, WI, USA) following the
manufacturer’s instructions. Transiently transfected cells were typi-
cally assayed after 24 h. Phase-contrast and £uorescence images
were recorded with an LSM510-V2.01 system (Carl Zeiss, Jena, Ger-
many).
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2.3. Preparation and analysis of cell extracts
Protein lysates were prepared by treating monolayers of cells with
lysis bu¡er (10 mM Tris^HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA,
1% NP40) supplemented with a protease-inhibitor cocktail (Complete
Mini; Roche, Basel, Switzerland). The concentration of proteins in
lysates was determined by a standard dye-binding assay (Bio-Rad
Protein Assay; Bio-Rad, CA, USA). 50 Wg aliquots of total protein
were resolved on a 10% SDS^polyacrylamide gel and transferred to a
PVDF membrane. Immunoblotting was performed by standard meth-
ods using a polyclonal anti-Bak antibody (#sc-832; Santa Cruz), a
polyclonal anti-actin antibody (#sc-7210; Santa Cruz) and anti-green
£uorescence protein (GFP) antibody (a gift from Dr. Nagasaki, AIST,
Tsukuba, Japan).
2.4. Analysis by reverse transcriptase-PCR (RT-PCR)
Total RNA was prepared from transfected cells at 70^80% con£u-
ency by using the Isogen reagent (Nippon Gene, Tokyo, Japan).
cDNA was synthesized using 2 Wg total RNA and M-MLV reverse
transcriptase (Promega, WI, USA). PCR was performed by using the
following gene and ribozyme speci¢c primers. Bak sense 5P-GAA TTC
ATG GCT TCG GGG CAA GGC CCA-3P and antisense 5P-GGA
TCC TCA TGA TTT GAA GAA TCT TCG T-3P ; L-actin sense 5P-
GCA CGG CAT CGT CAC CAA CT-3P and antisense 5P-AGG GCT
GGA AGA GTG CCT CA-3P ; DHFR dihydrofolate reductase sense
5P-ATG GTT GGT TCG CTA AAC TGC A-3P and antisense 5P-
CTG GGT ATT CTG GCA GAA GT-3P ; caspase 3 sense 5P-ATG
GAG AAC ACT GAA AAC TCA GT-3P and antisense 5P-TTA GTG
ATA AAA ATA GAG TTC TT-3P ; and Bak-ribozymes sense 5P-TCC
CCG GTT CGA AAC CGG GCA CTA C-3P and antisense 5P-AGA
AAA AAA GAT ATC CGG GGT ACC-3P. The ampli¢ed DNA
fragments were examined by gel electrophoresis and con¢rmed for
the expected size of ampli¢ed gene fragments.
2.5. Assay of TNF-K-induced apoptosis
Cells were seeded in six-well plates and treated with mouse recombi-
nant TNF-K (100 ng/ml; Sigma, MD, USA) and cycloheximide
(CHX; 5 Wg/ml; Sigma, MD, USA) for 24 h. Cells were washed twice
with phosphate-bu¡ered saline and harvested with trypsin-EDTA (1^
0.5 mM). Cells in each well were counted. The ratio of surviving
to dead cells was estimated by comparing the number of cells with
TNF-K treatment to that of untreated batches. Three independent
experiments were performed.
Fig. 1. E¡ects of expression of GFP-Bak in MCF-7 cells. a: Cells that expressed GFP, as a control, remain alive. b and c: Cells that expressed
GFP-Bak died, whereas cells that did not emit green £uorescence (namely cells that did not express GFP-Bak) were alive (c). d: Cells in which
DsRed1-Mito was localized in mitochondria. e: Cells that co-expressed DsRed1-Mito and GFP-Bak.
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Fig. 2. Expression levels and their e¡ects of Bak and GFP-Bak in MCF-7 and HeLa S3 cells. A: RT-PCR and immunoblotting analyses for
the expression of caspase 3, Bak and GFP in MCF-7 and HeLa S3 cells. Upper panel: the caspase 3 mRNA in MCF-7 cells (lane 1) was
shorter than that in HeLa S3 cells (lane 2). This deletion results in abrogation of translation of the mRNA. Middle panel: comparison of en-
dogenous Bak expression between MCF-7 and HeLa S3 cells. The levels of Bak in MCF-7 cells (lane 1) and HeLa S3 cells (lane 2) were clearly
di¡erent. Expression levels of actin are also shown as an internal control. Lower panel: cell lysates were analyzed 24 h after transfections of
GFP expression vector (lane 2) or GFP-Bak expression vector (lane 3) or Mock (lane 1). B: In HeLa S3 cells, GFP-Bak did not cause cell
death in a transient transfection assay. a: Cells that expressed GFP as a control and (b) cells that express GFP-Bak. c: GFP and DsRed1-
Mito proteins were localized to mitochondria. d: DsRed1-Mito and GFP-Bak were colocalized in mitochondria.
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3. Results and discussion
3.1. Overexpression of Bak in MCF-7 cells
We examined the e¡ects of the expression of Bak using an
expression plasmid that encoded a GFP-Bak fusion protein.
When MCF-7 cells (a line of human breast carcinoma) were
transfected with plasmid DNA encoding GFP-Bak, the cells
died, but no cell death was observed with the expression of
GFP alone (Fig. 1). Most noticeably, the untransfected cells
(lacking green £uorescence) remained viable in the mix culture
of transfected and untransfected cells (Fig. 1c, a dead £uores-
cent cell, left, is accompanied by a living non-£uorescent cell,
right). From these data, Bak appeared to be toxic to MCF-7
cells. These cells have lost caspase 3 owing to a 47 bp deletion
within exon 3 of the gene (Fig. 2A, upper panel) [22]. These
results suggested that Bak may function in the absence of
caspase 3, an important mediator of apoptosis, by a caspase
3-independent pathway.
Fig. 3. Cell death e¡ect of Bak. A: MCF-7 cells that expressed GFP-Bak were dead (a). By contrast, most MCF-7 cells that expressed GFP
(b), HeLa S3 cells that expressed GFP-Bak (c), or GFP (d) were alive. B: Transfection e⁄ciency was monitored by green £uorescence. Cell
death was examined in terms of changes in cell morphology and trypan blue staining. Data are presented as the meanTS.D. of results of three
independent experiments performed in triplicate. Scale bar indicates 50 Wm.
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3.2. Overexpression of Bak in HeLa S3 cells
We next examined the e¡ect of exogenous Bak (GFP-
tagged Bak) in caspase 3-expressing cells (HeLa S3). To our
surprise, HeLa S3 cells expressing GFP-Bak (as con¢rmed by
Western blotting, Fig. 2A, lane 2) did not die. Previous studies
have demonstrated that mitochondria are an important source
and ampli¢er of apoptotic signals, and that many apoptosis-
inducing factors, such as Bax, Bid and Bad, are localized in
mitochondria [23]. Therefore, we next examined the mito-
chondrial localization of GFP-Bak by performing cotransfec-
tion and double coimmunolocalization analysis of pDs-Red1-
Mito, DsRed £uorescent protein fused to a mitochondrion-
targeting peptide sequence (Clontech) and GFP-Bak in HeLa
S3. The two £uorescent proteins were co-localized (Fig. 2B, d)
in the mitochondria. These data indicated the possibility that
GFP-Bak might act via a similar mitochondrion-dependent
machinery by recruiting other pro-apoptotic factors.
To examine the factors responsible for the di¡erence in
sensitivity to Bak of MCF-7 cells and HeLa S3 cells, we ¢rst
examined the level of expression of the endogenous Bak in
these cells (Fig. 2A). HeLa S3 (lane 2) showed a considerably
higher level of expression of Bak than MCF-7 cells (lane 1).
The di¡erential e¡ect of exogenous Bak in HeLa S3 and
MCF-7 cells might be interpreted as follows. HeLa S3 cells
may have escaped Bak-mediated apoptotic cell death by
mechanism(s) that remain unknown in this study. These cells
appear to tolerate higher levels of endogenous Bak. In con-
trast, MCF-7 cells have a lower level of endogenous expres-
sion and remain sensitive to Bak-mediated apoptotic cell
death. We next addressed this issue by stably expressing exog-
enous Bak, reasoning that if the apoptotic pathway mediated
by Bak is inactivated, it should be possible to isolate Bak-
overexpressing stable HeLa S3 clones. However, in the pres-
ence of a functional Bak apoptotic pathway, it should be
impossible to generate such HeLa S3 clones. Stable transfec-
tion and subsequent antibiotic selection of HeLa S3 cells re-
sulted in hundreds of colonies in empty vector-transfected
cells. Only a few colonies appeared from Bak-transfected cells,
and when analyzed for Bak expression, these cells did not
appear to have a higher level of expression than that of the
control cells (data not shown). Thus, we failed to obtain HeLa
S3 cells that stably overexpressed exogenous Bak. This result
seems to support the conclusion that although HeLa S3 cells
Fig. 4. The putative secondary structure of Bak mRNA and of the ribozymes used in this study. A: Partial structure of Bak mRNA corre-
sponding to nucleotides 1^298, according to the numbering of [19]. Red lines indicate the target sites of hammerhead ribozymes, as indicated.
The sequence identi¢ed by the gene discovery system based on hybrid-ribozyme libraries is indicated by green letters [11]. B: Structures of the
ribozymes directed against Bak mRNA. Blue letters indicate the ribozyme.
Fig. 3 (Continued).
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were not as sensitive as MCF-7 cells to the e¡ects of Bak, the
apoptotic pathways induced by Bak are not inactive in these
cells (see quantitative data in Fig. 3). Although HeLa S3 cells
were able to escape apoptosis induced by transient overexpres-
sion of Bak, they were sensitive to the e¡ects of constitutive
Bak expression.
3.3. Construction of hammerhead ribozymes speci¢cally
targeted to Bak mRNA
To further elucidate the molecular basis of Bak action, we
constructed two kinds of hammerhead ribozymes targeted
speci¢cally to Bak mRNA (Bak-ribozymes) for inhibition of
the intracellular expression of Bak. Hammerhead ribozymes
are catalytic RNA molecules that bind to speci¢c RNA target
molecules via complementary sequences and then cleave their
RNA targets enzymatically [1^8]. The selection of target sites
within Bak mRNA for cleavage by ribozymes (Fig. 4A) was
based on the following four criteria: (1) the requirement for a
NUX triplet at the target sequence [24^26], (2) the expectation
that the target sites and their £anking regions should not form
a duplex by themselves (target sites have an open structure),
(3) the Bak-ribozymes would adopt the expected conforma-
tions as recognition arms of ribozymes and not form a tight
duplex by themselves, and (4) the overall structure to maintain
a cloverleaf motif of tRNAVal so that they can be transported
to the cytoplasm (Fig. 4B and [4^8]). We predicted the sec-
ondary structures of Bak mRNA and the Bak-ribozymes us-
ing the Mfold program [27]. The selected target sites of the
ribozymes were both CUC triplets in Bak mRNA (Fig. 4A).
3.4. Elimination of Bak from MCF-7 cells
Plasmids that contained a Bak-ribozyme were transfected
into MCF-7 cells and cells were selected by incubation in
puromycin-containing medium for 4 weeks. The expression
of Bak-ribozymes was con¢rmed by RT-PCR (Fig. 5, upper
panel, lanes 3 and 4). To examine the level of Bak mRNA in
Bak-ribozyme-expressing cells, we performed RT-PCR analy-
sis for Bak. As compared to the control cells, the level of Bak
mRNA was signi¢cantly reduced in MCF-7 cells that stably
expressed the Bak-ribozyme#2 (Bak-Rz#2 in the middle panel
in Fig. 5, lane 4). By contrast, no signi¢cant di¡erence was
found in the case of cells that expressed Bak-ribozyme#1 (lane
3). The di¡erence between cells that expressed Bak-ribo-
zyme#1 and Bak-ribozyme#2 might be due to the secondary
conformation of Bak mRNA and its accessibility to the re-
spective ribozymes (Fig. 4A). There were no di¡erences in the
respective levels of expression of L-actin mRNA and DHFR
mRNAs, which served as internal controls, between Bak-ribo-
zyme-expressing and control cells (Fig. 5, lower panels).
3.5. Assay of TNF-K-induced apoptosis
We subjected MCF-7 cells that stably expressed the active
Bak-ribozyme#2 to an assay of TNF-K-induced apoptosis to
examine the role of Bak in TNF-K-induced apoptosis. The
percentage of Bak-ribozyme#2-expressing cells after exposure
to TNF-K and CHX (lane 3) was somewhat greater than that
of tRNAVal-expressing (lane 2) or wild-type (lane 1) MCF-7
cells (Fig. 6). Therefore, it seems likely that Bak participates,
at least to some extent, in TNF-K-mediated apoptosis in
MCF-7 cells.
The cellular death process is the result of the interactions of
complex pathways involving many factors and signaling mol-
ecules. Thus, a defect in Bak alone would not necessarily be
expected to have a dramatic e¡ect on apoptosis. Previously,
we identi¢ed Bak using our novel gene discovery system with
Fig. 5. Levels of expression of Bak mRNA in MCF-7 cells as deter-
mined by RT-PCR. A reduction in the level of Bak expression was
detected in cells that expressed Bak-ribozyme#2 (lane 4) but not in
cells that expressed Bak-ribozyme#1 (lane 3). Lane 1, non-trans-
fected MCF-7 cells; lane 2, cells that expressed the control tRNAVal
(ribozyme (^)); and lanes 3 and 4, cells that expressed Bak-ribo-
zyme#1 and Bak-ribozyme#2. As internal controls for RT-PCR, re-
sults for L-actin and DHFR transcripts are also shown. The levels
of expression of Bak-ribozyme#1, Bak-ribozyme#2 and the control
tRNAVal (ribozyme (^)) were also con¢rmed (top panel). A reduc-
tion in level of Bak mRNA was con¢rmed by three independent ex-
periments.
Fig. 6. Assay of TNF-K-induced cell death. The ratio of living to
dead cells was determined for cells treated with TNF-K and CHX
for 24 h and those that were not treated (see text for details). Re-
sults are shown for cells that expressed Bak-ribozyme#2 (column 3),
non-transfected MCF-7 cells (column 1), and as a negative control,
cells that had been treated with tRNAVal expression plasmids with-
out a ribozyme sequence (column 2). Each column and bar repre-
sent the meanTS.D. of results of three independent experiments
performed in triplicate.
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randomized ribozyme libraries in the TNF-K-mediated apo-
ptosis pathway [11]. This identi¢cation was possible because
the percentage of surviving cells that expressed Bak-ribozymes
after exposure to TNF-K was greater than that of wild-type
MCF-7 cells, as con¢rmed in this study. We also con¢rmed by
£uorescent microscopy the mitochondrial localization of Bak.
This study demonstrates for the ¢rst time that in addition to
its caspase-dependent function, Bak is involved in TNF-K-
induced apoptosis in a caspase-independent manner.
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